Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study
ConclusionsWe confirm the high prevalence of ID and anemia in cancer patients. ID status is correlated to tumor response providing a strong rationale for iron monitoring during cancer management.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Epidemiology | Iron | Lymphoma | Study